People · Operator
Named in public records as an officer, director or promoter · active 2014–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Embera Neurotherapeutics, Inc. | — | Pharmaceuticals | Series A | $14.6M | $189.8M | 2014 |
Joseph B. Lovett at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph B. Lovett on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Franz Hefti | 1 | 6 |
| Ross Barrett | 1 | 5 |
| Ross P. Barrett | 1 | 4 |
| Joseph Lovett | 1 | 4 |
| Joseph P. Lovett | 1 | 2 |
| Robert Linke | 1 | 2 |
| Robert B. Linke | 1 | 1 |
| John B. Beaird | 1 | 1 |
| Nicholas E. Goeders | 1 | 1 |
| Franz P. Hefti | 1 | 1 |
| Nicholas Goeders | 1 | 1 |
| Franz B. Hefti | 1 | 1 |
| Ross B. Barrett | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.